AEYE Diagnostic Screening (AEYE-DS)
Provider 
Founded 2018
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed

AEYE Diagnostic Screening is an autonomous AI product for point-of-care diabetic retinopathy screening by healthcare providers.
AEYE Diagnostic Screening (AEYE-DS) is an autonomous AI diagnostic screening product for diabetic retinopathy. Healthcare providers use it to detect more-than-mild diabetic retinopathy in adults with diabetes who have not previously been diagnosed with the condition.
AEYE-DS analyzes retinal images and provides results at the point of care without specialist over-read. The system is indicated for use with the Topcon NW400 and Optomed Aurora retinal cameras.
Adds products that compete with one of AEYE Diagnostic Screening (AEYE-DS)’s direct competitors but not with AEYE Diagnostic Screening (AEYE-DS) itself. They are shaded, and Linked Through names the direct competitor each one competes with.
| Attribute | AEYE Diagnostic Screening (AEYE-DS) | LumineticsCore | IRIS Testing for Diabetic Retinopathy | |
|---|---|---|---|---|
| Linked Through | — | Direct competitor | LumineticsCore | |
| Provider | ||||
| Founded | 2018 | 2010 | 1997 | |
| Sells To | Enterprise | B2B, Enterprise | Enterprise | |
| Pricing Model | Recurring, Software | Licensing, Recurring, Software | Recurring, Software | |
| Ownership | Venture-backed | Private | Public |
Provider 
Founded 2018
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed
Provider 
Founded 2010
Sells To B2B, Enterprise
Pricing Model Licensing, Recurring, Software
Ownership Private
Linked Through LumineticsCore
Provider 
Founded 1997
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public


IRIS retinal imaging technology supports diabetic retinopathy screening and specialist interpretation.
IRIS retinal imaging technology supports diabetic retinopathy screening and specialist interpretation.
